Cargando…
Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
BACKGROUND: Bortezomib (BZM), alone or in combination with other chemotherapies, has displayed strong anticancer effects in several cancers. The efficacy of the combination of BZM and mitoxantrone (MTX) in treating prostate cancer remains unknown. METHODS: Anticancer effects of combination of BZM an...
Autores principales: | Zhang, Ying, Liu, Qiuzi, Wei, Wei, Zhang, Guoan, Yan, Siyuan, Dai, Rongrong, Sun, Ying, Su, Dubo, Lv, Shun, Xia, Yong, Li, Jing, Li, Changlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515742/ https://www.ncbi.nlm.nih.gov/pubmed/34645397 http://dx.doi.org/10.1186/s12885-021-08841-1 |
Ejemplares similares
-
Alternol triggers immunogenic cell death via reactive oxygen species generation
por: Li, Changlin, et al.
Publicado: (2021) -
Effect of bortezomib on proliferation and apoptosis of myeloma cells by activating Wnt/β-catenin signaling pathway
por: Dai, Yanling, et al.
Publicado: (2020) -
Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway
por: Jin, Yulong, et al.
Publicado: (2019) -
The Antitumor Activity of Antrodia camphorata in Melanoma Cells: Modulation of Wnt/β-Catenin Signaling Pathways
por: Hseu, You-Cheng, et al.
Publicado: (2012) -
Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects
por: Jin, Xi-Feng, et al.
Publicado: (2020)